APA
Chokchaichamnankit D., Watcharatanyatip K., Subhasitanont P., Weeraphan C., Keeratichamroen S., Sritana N., Kantathavorn N., Diskul-Na-Ayudthaya P., Saharat K., Chantaraamporn J., Verathamjamras C., Phoolcharoen N., Wiriyaukaradecha K., Paricharttanakul N. M., Udomchaiprasertkul W., Sricharunrat T., Auewarakul C., Svasti J. & Srisomsap C. (2019). Urinary biomarkers for the diagnosis of cervical cancer by quantitative label-free mass spectrometry analysis. : Oncology letters.
Chicago
Chokchaichamnankit Daranee, Watcharatanyatip Kamolwan, Subhasitanont Pantipa, Weeraphan Churat, Keeratichamroen Siriporn, Sritana Narongrit, Kantathavorn Nuttavut, Diskul-Na-Ayudthaya Penchatr, Saharat Kittirat, Chantaraamporn Juthamard, Verathamjamras Chris, Phoolcharoen Natacha, Wiriyaukaradecha Kriangpol, Paricharttanakul Nilubol Monique, Udomchaiprasertkul Wandee, Sricharunrat Thaniya, Auewarakul Chirayu, Svasti Jisnuson and Srisomsap Chantragan. 2019. Urinary biomarkers for the diagnosis of cervical cancer by quantitative label-free mass spectrometry analysis. : Oncology letters.
Harvard
Chokchaichamnankit D., Watcharatanyatip K., Subhasitanont P., Weeraphan C., Keeratichamroen S., Sritana N., Kantathavorn N., Diskul-Na-Ayudthaya P., Saharat K., Chantaraamporn J., Verathamjamras C., Phoolcharoen N., Wiriyaukaradecha K., Paricharttanakul N. M., Udomchaiprasertkul W., Sricharunrat T., Auewarakul C., Svasti J. and Srisomsap C. (2019). Urinary biomarkers for the diagnosis of cervical cancer by quantitative label-free mass spectrometry analysis. : Oncology letters.
MLA
Chokchaichamnankit Daranee, Watcharatanyatip Kamolwan, Subhasitanont Pantipa, Weeraphan Churat, Keeratichamroen Siriporn, Sritana Narongrit, Kantathavorn Nuttavut, Diskul-Na-Ayudthaya Penchatr, Saharat Kittirat, Chantaraamporn Juthamard, Verathamjamras Chris, Phoolcharoen Natacha, Wiriyaukaradecha Kriangpol, Paricharttanakul Nilubol Monique, Udomchaiprasertkul Wandee, Sricharunrat Thaniya, Auewarakul Chirayu, Svasti Jisnuson and Srisomsap Chantragan. Urinary biomarkers for the diagnosis of cervical cancer by quantitative label-free mass spectrometry analysis. : Oncology letters. 2019.